Joseph AlvarÂnas, MD, direcÂtor of value-based analytics at City of Hope, Duarte, California, and editor-in-chief of Evidence-Based Oncology painted an upbeat picture of cancer cure rates at the 2015 meeting of Patient-Centered Oncology Care.
Joseph Alvar­nas, MD, direc­tor of value-based analytics at City of Hope, Duarte, California, and editor-in-chief of Evidence-Based Oncology painted an upbeat picture of cancer cure rates at the 2015 meeting of Patient-Centered Oncology Care.
During his session, Dr Alvarnas outlined the rapid changes in medicine and the profound impact the development of targeted immunotherapy agents have had on patient outcomes. Here are the slides from his session, slightly modified.
NCCN Launches Pilot Project Aiming to Measure, Implement Health Equity in Cancer Care Practices
February 4th 2023Five leading academic cancer centers are assessing the feasibility of implementing the Health Equity Report Card pilot project as a tool that can both meaningfully and feasibly measure and report on equitable care practices.
Read More
Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity
February 3rd 2022On this episode of Managed Care Cast, we speak with Meghan Gutierrez, CEO of the Lymphoma Research Foundation, about financial toxicity, how the pandemic has affected patients’ financial needs when they have cancer, health care disparities and care gaps, and more.
Listen
Study Suggests MRI Is the Best Breast Cancer Screening Modality for Dense Breasts
February 1st 2023A review and meta-analysis published in the journal Radiology found MRI to be the most effective supplemental breast cancer screening method for women with dense breasts and negative mammogram results.
Read More
Interstitial Lung Abnormalities Impact OS in NSCLC Patients Receiving CRT, Adjuvant Durvalumab
January 19th 2023Pretreatment interstitial lung abnormalities were associated with worse overall and cause-specific survival in Japanese patients receiving chemoradiotherapy followed by adjuvant durvalumab for locally advanced non–small-cell lung cancer.
Read More
2 Clarke Drive
Cranbury, NJ 08512